IP Library Granted Patent US 7,037,700
Granted Patent B2
US 7,037,700 · App. 10/631,958 · Granted May 2, 2006

Regulation of human ceramide kinase

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,037,700
App. No.
10/631,958
Granted
May 2, 2006
Kind
B2
Abstract

Reagents that regulate human ceramide kinase protein activity and reagents that bind to human ceramide kinase gene products can be used to regulate intracellular signaling and consequently cell proliferation and apoptosis. Such regulation is particularly useful for treating allergies including but not limited to asthma, autoimmune diseases such as rheumatoid arthritis, inflammatory disease, transplant rejection, and cancer, particularly lymphocytic leukemias, and could be a useful target of vaccination enhancing adjuvants. Central and peripheral nervous system disorders, such as Parkinson's disease, also can be treated.

Claims (7)

1. A purified polypeptide comprising an amino acid sequence selected from the group consisting of the amino acid sequences shown in SEQ ID NOS:10, and 11 and.

2. The purified polypeptide of claim 1 which comprises the amino acid sequence shown in SEQ ID NO:10.

3. The purified polypeptide of claim 1 which comprises the amino acid sequence shown in SEQ ID NO:11.

4. A fusion protein comprising a polypeptide consisting of an amino acid sequence selected from the group consisting of the amino acid sequence shown in SEQ ID NOS:10, and 11.

5. A kit for detecting a polypeptide comprising an amino acid sequence selected from the group consisting of an amino acid sequence selected from the group consisting of SEQ ID NOS:10, and 11, comprising:

an antibody which specifically binds to the polypeptide; and instructions for the method of detecting said polypeptide comprising the steps of: contacting a biological sample with said antibody to form a reagent-polypeptide complex; and

detecting the antibody-polypeptide complex.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 20, 2013
From: BAYER PHARMA AG
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 029839/0959 →
CHANGE OF NAME Recorded Oct 18, 2012
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER PHARMA AG
Reel/Frame 029150/0303 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2009
From: BAYER AG
To: BAYER SCHERING PHARMA AG
Reel/Frame 022510/0628 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 2, 2009
From: BAYER AG
To: BAYER SCHERING PHARMA AG
Reel/Frame 022482/0990 →